Proteome Sciences plc (LON:PRM – Get Free Report)’s share price traded up 2.6% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.15 ($0.04). 555,891 shares changed hands during trading, an increase of 247% from the average session volume of 160,411 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Trading Up 3.5 %
The company has a market capitalization of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07. The firm’s 50 day moving average price is GBX 2.72 and its two-hundred day moving average price is GBX 3.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Most Volatile Stocks, What Investors Need to Know
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- How to Use Stock Screeners to Find Stocks
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
